Abstract

Tissue-resident Natural Killer (trNK) cells are crucial components of local immunity that activate rapidly upon infection. However, under steady state conditions, their responses are tightly controlled to prevent unwanted tissue damage. The mechanisms governing their differentiation and activation are not fully understood. Here, we characterise uterine trNK cells longitudinally during pregnancy by single cell RNA sequencing and find that the combined expression pattern of 4-1BB and CD55 defines their three distinct stages of differentiation in mice. Mechanistically, an IL-21R-STAT3 axis is essential for initiating the trNK cell differentiation. The fully differentiated trNK cells demonstrate enhanced functionality, which is necessary for remodelling spiral arteries in the decidua. We identify an apoptotic program that is specific to the terminal differentiation stage, which may preclude tissue damage by these highly activated trNK cells. In summary, uterine trNK cells become intensely active and effective during pregnancy, but tightly controlled via a differentiation program that also limits potential harm, suggesting an intricate mechanism for harnessing trNK cells in maintaining pregnancy.

Uterine natural killer (NK) cells support tissue homeostasis in the uterus during pregnancy, but it is not fully known how they differentiate into potentially cytotoxic effector cells while avoiding tissue damage. Here authors show that Il21 receptor signalling via STAT3 activation governs their differentiation, while an apoptotic cell death program ensures that harm is limited.

Details

Title
IL-21R-STAT3 signalling initiates a differentiation program in uterine tissue-resident NK cells to support pregnancy
Author
Han, Mengwei 1 ; Hu, Luni 1 ; Wu, Di 1 ; Zhang, Yime 1 ; Li, Peng 1 ; Zhao, Xingyu 1 ; Zeng, Yanyu 1 ; Ren, Guanqun 1 ; Hou, Zhiyuan 1 ; Pang, Yanli 2 ; Zhao, Tongbiao 3   VIAFID ORCID Logo  ; Zhong, Chao 4   VIAFID ORCID Logo 

 Peking University Health Science Center, Institute of Systems Biomedicine, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, Beijing, China (GRID:grid.11135.37) (ISNI:0000 0001 2256 9319) 
 Peking University Third Hospital, Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Beijing, China (GRID:grid.411642.4) (ISNI:0000 0004 0605 3760) 
 Chinese Academy of Sciences, National Stem Cell Resource Center, State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Institute for Stem Cell and Regeneration, Beijing, China (GRID:grid.9227.e) (ISNI:0000000119573309) 
 Peking University Health Science Center, Institute of Systems Biomedicine, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, Beijing, China (GRID:grid.11135.37) (ISNI:0000 0001 2256 9319); Peking University, NHC Key Laboratory of Medical Immunology, Beijing, China (GRID:grid.11135.37) (ISNI:0000 0001 2256 9319); Chinese Academy of Medical Sciences, Key Laboratory of Molecular Immunology, Beijing, China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839) 
Pages
7109
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2885954877
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.